STOCK TITAN

NASDAQ Biotechnology Index Stock Price, News & Analysis

nbi

Company Description

NASDAQ Biotechnology Index (Nasdaq: nbi) is a publicly traded company.

nbi stock has declined 100.0% over the past year.

This page provides a comprehensive overview of nbi stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$—
0.00%
0.00
Last updated:
-100%
Performance 1 year

NASDAQ Biotechnology Index (nbi) stock. Over the past 12 months, the stock has lost 100.0%.

Latest News

NASDAQ Biotechnology Index has 10 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 4 with negative movement. Key topics include earnings. View all nbi news →

SEC Filings

No SEC filings available for nbi.

Financial Highlights

Revenue (TTM)
Net Income (TTM)
Operating Cash Flow

Upcoming Events

JAN
14
January 14, 2027 Financial

Options first vesting

Options covering 8,775 shares: one-third vests on first anniversary of grant
JAN
14
January 14, 2029 Financial

RSU vesting and settlement

1,738 restricted stock units vest and settle per 3-year schedule from grant
JAN
14
January 14, 2033 Financial

Options expiration

Unexercised stock options expire seven years after the Jan 14, 2026 grant date

NASDAQ Biotechnology Index has 3 upcoming scheduled events. The next event, "Options first vesting", is scheduled for January 14, 2027 (in 289 days). 3 of the upcoming events are financial in nature, such as earnings calls or quarterly results. Investors can track these dates to stay informed about potential catalysts that may affect the nbi stock price.

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months